Diabetes Screening in Thailand Your guide to cost, top specialists & hospitals

Our partner hospitals in Bangkok operate JCI-accredited laboratories with automated glucose and HbA1c analysers calibrated to DCCT/IFCC standards. OGTT protocols follow WHO guidelines exactly, ensuring your results are clinically valid and internationally comparable.

Results are reviewed by physicians trained in endocrinology or internal medicine who specialise in metabolic health. They interpret your glucose markers alongside insulin levels, lipid profile, and body composition data to identify the specific metabolic pathway driving your risk.

Confirm the laboratory uses DCCT/IFCC-standardised HbA1c assays. Ask whether results are reviewed by a physician with metabolic or endocrine expertise. Check that the clinic can run an OGTT if your fasting results are borderline, rather than sending you elsewhere.

Most patients receive results confirming normal glucose regulation. A meaningful proportion, particularly those over 40 with sedentary lifestyles, will be in the pre-diabetic range without knowing it. For these patients, screening is the intervention, because lifestyle changes implemented at the pre-diabetic stage can prevent progression to full diabetes in the majority of cases.

Your physician provides specific recommendations based on where your markers fall. Normal results warrant periodic rescreening. Pre-diabetic results trigger a structured lifestyle plan covering diet, exercise, and weight targets, with a follow-up testing schedule. Diabetic-range results require medical management and potentially referral to an endocrinologist.

Diabetes screening in Thailand typically costs between $120 and $250 depending on the panel tier. A standard glucose panel with fasting glucose, HbA1c, and insulin sits at the lower end. Comprehensive panels adding OGTT, HOMA-IR, and linked metabolic markers cost more. Advanced panels with cardiovascular and thyroid markers sit at the upper end.

The number and type of markers tested drive the cost. Adding an OGTT increases laboratory time and reagent costs. Advanced markers like C-peptide, fructosamine, and microalbumin ratios require specialised assays. Physician consultation level (generalist versus endocrinologist) also affects the total.

Pricing varies by the complexity and scope of the procedure. Typical ranges at our partner hospitals in Thailand:

• Fasting glucose test: $120–$140. Single blood draw measuring blood sugar after an overnight fast
• HbA1c test: $140–$170. Three-month average blood sugar level, no fasting required
• Comprehensive diabetes panel (glucose + HbA1c + insulin + C-peptide): $170–$200. Full metabolic assessment for early detection and risk stratification

Exact pricing is confirmed after your consultation and treatment plan are finalised.

A comprehensive diabetes screening that costs $250–$500 in the US or £200–£350 in the UK typically costs $120–$250 in Thailand using the same laboratory standards, assays, and diagnostic guidelines. The saving is even greater when combined with other wellness tests during the same visit.

One to two days is sufficient. Blood is drawn and, if included, the OGTT completed on day one. Results are reviewed the same afternoon. If results are abnormal and additional testing is needed, a second day provides time for follow-up without rushing.

Your physician will explain the results and recommend next steps, which may include dietary and lifestyle changes, repeat testing in three to six months, or referral to an endocrinologist. Early detection of pre-diabetes means you often have time to reverse the trend with lifestyle adjustments alone.

For adults over 35 with no risk factors, every three years is generally sufficient. If you have risk factors such as family history, overweight, previous borderline results, or PCOS, annual screening is recommended. Your physician will advise based on your individual results.

Yes. HbA1c and fasting glucose assays used at our partner laboratories follow WHO and American Diabetes Association diagnostic criteria. Equipment is calibrated to DCCT/IFCC standards, ensuring results are directly comparable to those from any accredited laboratory worldwide.

Pre-diabetes is not a disease; it is a warning. An HbA1c between 42 and 47 mmol/mol, or a fasting glucose in the impaired range (6.1–6.9 mmol/L under WHO criteria, or 5.6–6.9 mmol/L under the slightly stricter ADA criteria), means your body is struggling to regulate glucose efficiently. With dietary changes, increased physical activity, and weight management, most people with pre-diabetes can return their markers to normal and significantly reduce their risk of progressing to type 2 diabetes⁴.

This screening is primarily designed to assess risk for type 2 diabetes and pre-diabetes. However, markers such as C-peptide and fasting insulin can provide clues about insulin production. If type 1 diabetes is suspected, your physician can arrange specific autoantibody testing.

An 8–12 hour overnight fast is required for accurate fasting glucose and insulin results. Drink water normally during the fasting period but avoid food, juice, coffee, and tea. Bring a list of current medications and supplements, as some can affect glucose markers.

Diabetes screening combines naturally with a broader blood panel, full body screening, or metabolic testing. Since the blood draw is already done, adding glucose markers to an existing panel is simply a matter of running additional assays on the same sample.

If repeat testing is recommended, your care coordinator can arrange blood work at a local laboratory near your home, with results reviewed by your Thai physician via telemedicine. This creates a continuous monitoring loop without requiring additional trips.